Pharmaceutical products
supply status

From time to time we may experience shortages of some products and may divest or discontinue others.

 

MSD UK customer services

01992 452094

(During public holidays please contact our UK switchboard on 01992 467272).

 

Emergency patient supply order form

Please click here to download an emergency patient supply order form (for use by UK healthcare professionals only).

Supply Status

Product Description
Supply Status
Estimated Resupply Date
ASMANEX® Twisthaler® 200 micrograms Inhalation Powder 30 Dose
Out of Stock
Late February 2020
EMEND® 125 mg powder for oral suspension
Out of Stock
Mid March 2020
NOXAFIL® 100 mg gastro-resistant 2 X 12 TAB
Low stock
Intermittent Supply until Q1 2020
NOXAFIL® 100 mg gastro-resistant 8 X 12 TAB
Out of Stock
Intermittent Supply until Q1 2020
ZOELY® 2.5 mg/1.5 mg film-coated Tablets
Out of Stock
Q1 2022

Notifications

KEYTRUDA▼ (pembrolizumab) – 50 mg vial supply arrangements

During the month of June 2019 onwards pembrolizumab will cease to be available in the 50 mg vial as lyophilised powder (50 mg powder for concentrate for solution for infusion). It will be supplied by MSD in the UK exclusively in the form of 100 mg vial (25 mg/mL concentrate for solution for infusion).

As this date is determined by the level of the demand for this presentation a precise date cannot be provided. As such we recommend that all Trusts take appropriate steps to ensure they are able to use the 100 mg presentation.

  • Product Description
  • COZAAR® 2.5 mg/ml powder and solvent for oral suspension

This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck & Co., Inc., Kenilworth, NJ, USA, its subsidiaries or affiliates, except as noted.

Job code: GB-NON-01882Date of preparation: November 2019